Citadel Advisors
RCEL icon

Citadel Advisors’s Avita Medical RCEL Stock Holding History

Citadel Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.8K Buy
25,624
+5,434
+27% +$22.8K ﹤0.01% 12058
2025
Q4 		$69.7K Buy
+20,190
New +$80.6K ﹤0.01% 11868
2025
Q3 		– Sell
-58,761
Closed -$307K – 13857
2025
Q2 		$311K Buy
+58,761
New +$427K ﹤0.01% 9734
2025
Q1 		– Sell
-16,319
Closed -$152K – 15383
2024
Q4 		$209K Sell
16,319
-14,563
-47% -$172K ﹤0.01% 10380
2024
Q3 		$331K Buy
30,882
+5,981
+24% +$56.2K ﹤0.01% 9125
2024
Q2 		$197K Buy
24,901
+7,171
+40% +$68.2K ﹤0.01% 9965
2024
Q1 		$284K Buy
17,730
+14,367
+427% +$233K ﹤0.01% 9568
2023
Q4 		$46.1K Sell
3,363
-13,768
-80% -$158K ﹤0.01% 11856
2023
Q3 		$250K Buy
17,131
+12,596
+278% +$213K ﹤0.01% 9497
2023
Q2 		$77.1K Sell
4,535
-104,204
-96% -$1.53M ﹤0.01% 11286
2023
Q1 		$1.52M Buy
108,739
+66,507
+157% +$708K ﹤0.01% 5887
2022
Q4 		$279K Buy
42,232
+16,721
+66% +$100K ﹤0.01% 9477
2022
Q3 		$135K Sell
25,511
-61,628
-71% -$381K ﹤0.01% 10827
2022
Q2 		$414K Buy
+87,139
New +$538K ﹤0.01% 9076
2022
Q1 		– Sell
-13,628
Closed -$126K – 14406
2021
Q4 		$163K Buy
+13,628
New +$208K ﹤0.01% 12159
2021
Q2 		– Sell
-56,562
Closed -$1.12M – 14284
2021
Q1 		$1.12M Buy
56,562
+25,304
+81% +$588K ﹤0.01% 7825
2020
Q4 		$581K Buy
31,258
+9,660
+45% +$212K ﹤0.01% 7870
2020
Q3 		$544K Buy
+21,598
New +$538K ﹤0.01% 7147
2020
Q1 		– Sell
-8,510
Closed -$387K – 10054
2019
Q4 		$387K Buy
+8,510
New +$354K ﹤0.01% 7205

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors's RCEL Position: Q1 2026 in Review

Citadel Advisors increased its Avita Medical (RCEL) stake by 27% in Q1 2026, buying an estimated $22.8K and bringing the position to 25,624 shares worth $94.8K. The position accounts for ﹤0.01% of the portfolio, ranked #12058.

Citadel Advisors first reported a position in RCEL in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.52M in Q1 2023. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Citadel Advisors held 25,624 shares of Avita Medical worth $94.8K as of Q1 2026.
  • Citadel Advisors bought 5,434 Avita Medical shares in Q1 2026, an estimated $22.8K.
  • Avita Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12058 holding.
  • Citadel Advisors first reported a position in Avita Medical in Q4 2019 and has held it in 19 quarters since.
  • Citadel Advisors's Avita Medical position peaked at $1.52M in Q1 2023.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.